• Join
  • Login
  • Contact

Search abstracts

Conversion from sirolimus to everolimus in kidney transplant recipients:The experience in a medical center in Taiwan

  • At: 2012 FIP Congress in Amsterdam (the Netherlands)
  • Type: Poster
  • By: WU, Chih-I (Changhua Christian Hospital, Pharmacy, Changhua, China Taiwan)
  • Co-author(s): Chen, C.H. (Changhua Christian Hospital, Changhua, China Taiwan)
    Ng, S.P. (Changhua Christian Hospital, Changhua, China Taiwan)
    Chien, S.Y. (Changhua Christian Hospital, Changhua, China Taiwan)
  • Abstract:


    This study investigated the optimal conversion dosage, efficacy and safety profile between everolimus (EVL) and sirolimus (SRL)


    The open-label, single-center study includes 16 kidney transplant recipients conversion from SRL to EVL. We analyzed the medical records and laboratory data, including dosage, serum creatinine,


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses